PMV Pharmaceuticals Inc. (PMVP)
PMV Pharmaceuticals Statistics
Share Statistics
PMV Pharmaceuticals has 51.93M shares outstanding. The number of shares has increased by 0.95% in one year.
| Shares Outstanding | 51.93M |
| Shares Change (YoY) | 0.95% |
| Shares Change (QoQ) | 0.36% |
| Owned by Institutions (%) | 75.54% |
| Shares Floating | 43.84M |
| Failed to Deliver (FTD) Shares | 176 |
| FTD / Avg. Volume | 0.15% |
Short Selling Information
The latest short interest is 837.51K, so 1.61% of the outstanding shares have been sold short.
| Short Interest | 837.51K |
| Short % of Shares Out | 1.61% |
| Short % of Float | 1.89% |
| Short Ratio (days to cover) | 9.62 |
Valuation Ratios
The PE ratio is -1.33 and the forward PE ratio is -0.64. PMV Pharmaceuticals's PEG ratio is 0.06.
| PE Ratio | -1.33 |
| Forward PE | -0.64 |
| PS Ratio | 0 |
| Forward PS | 0.4 |
| PB Ratio | 0.44 |
| P/FCF Ratio | -1.5 |
| PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for PMV Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.22, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.22 |
| Quick Ratio | 12.22 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.25M |
| Employee Count | 47 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -16.1M |
| Effective Tax Rate | 21.52% |
Stock Price Statistics
The stock price has increased by -39.78% in the last 52 weeks. The beta is 1.49, so PMV Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 1.49 |
| 52-Week Price Change | -39.78% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 50.03 |
| Average Volume (20 Days) | 117K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -85.45M |
| Net Income | -58.71M |
| EBITDA | -85.45M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.14 |
Balance Sheet
The company has 40.88M in cash and 1.19M in debt, giving a net cash position of 39.69M.
| Cash & Cash Equivalents | 40.88M |
| Total Debt | 1.19M |
| Net Cash | 39.69M |
| Retained Earnings | -368.71M |
| Total Assets | 191.29M |
| Working Capital | 161.29M |
Cash Flow
In the last 12 months, operating cash flow was -51.28M and capital expenditures -655K, giving a free cash flow of -51.94M.
| Operating Cash Flow | -51.28M |
| Capital Expenditures | -655K |
| Free Cash Flow | -51.94M |
| FCF Per Share | -1.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PMVP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PMVP is $5.5, which is 404.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.5 |
| Price Target Difference | 404.6% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -1.06 |
| Piotroski F-Score | 1 |